|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 47.35 USD | -2.29% |
|
+0.23% | -4.73% |
| 05-13 | Supernus Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:40 PM | |
| 05-05 | Supernus Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 05, 2026 |
| Market Cap | 2.75B 2.41B 2.23B 2.05B 3.89B 263B 3.96B 26.61B 10.44B 129B 10.32B 10.09B 446B | P/E 2026 * |
106x | P/E 2027 * | 31.6x |
|---|---|---|---|---|---|
| Enterprise Value | 2.75B 2.41B 2.23B 2.05B 3.89B 263B 3.96B 26.61B 10.44B 129B 10.32B 10.09B 446B | EV / Sales 2026 * |
3.17x | EV / Sales 2027 * | 2.69x |
| Free-Float |
95.54% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Supernus Pharmaceuticals, Inc.
| 1 day | -2.29% | ||
| 1 week | +0.23% | ||
| Current month | +1.81% | ||
| 1 month | +6.62% | ||
| 3 months | -5.21% | ||
| 6 months | -7.97% | ||
| Current year | -4.73% |
| 1 week | 46.91 |  | 51.37 |
| 1 month | 42.45 | | 51.37 |
| Current year | 42.45 | | 59.68 |
| 1 year | 32.2 | | 59.68 |
| 3 years | 21.99 | | 59.68 |
| 5 years | 21.99 | | 59.68 |
| 10 years | 13.12 | | 61.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jack Khattar
CEO | Chief Executive Officer | 64 | 2005-12-21 |
Timothy Dec
DFI | Director of Finance/CFO | 67 | 2021-08-22 |
| Compliance Officer | 63 | 2011-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Jack Khattar
BRD | Director/Board Member | 64 | 2005-12-21 |
Charles Newhall
CHM | Chairman | 81 | 2016-08-09 |
Frederick Hudson
BRD | Director/Board Member | 80 | 2010-11-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-15 | Fiscal year | Chief Technology Officer | 321,750 | 0.5738% | ||
| 03-12 | Others | Founder | 60,000 | 0.1070% | ||
| 03-11 | Sell | Director | 5,369 | 0.0096% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.29% | +0.23% | +42.96% | +56.32% | 2.81B | |
| +0.40% | -2.17% | +48.79% | +16.66% | 305B | |
| +0.11% | -2.07% | +23.98% | -6.05% | 69.44B | |
| -0.12% | -5.78% | +33.18% | +94.11% | 9.04B | |
| +1.50% | -1.68% | +7.84% | +0.64% | 8.56B | |
| -3.76% | -5.60% | -19.33% | +4.76% | 4.3B | |
| -2.06% | -6.09% | +11.75% | +24.59% | 4.09B | |
| -0.58% | -2.16% | -39.03% | +20.58% | 3.4B | |
| +0.49% | -3.46% | +10.78% | -20.63% | 2.14B | |
| -1.95% | -5.62% | -19.53% | +22.74% | 1.81B | |
| Average | -0.83% | -2.34% | +10.14% | +21.37% | 41.07B | |
| Weighted average by Cap. | +0.26% | -4.02% | +41.05% | +14.28% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 867M 761M 704M 648M 1.23B 83B 1.25B 8.4B 3.29B 40.76B 3.26B 3.19B 141B | 1.02B 897M 831M 765M 1.45B 97.9B 1.47B 9.9B 3.88B 48.08B 3.84B 3.76B 166B |
| Net income | 25.92M 22.74M 21.06M 19.38M 36.65M 2.48B 37.36M 251M 98.44M 1.22B 97.35M 95.22M 4.21B | 92.99M 81.57M 75.55M 69.51M 131M 8.9B 134M 900M 353M 4.37B 349M 342M 15.1B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-13 | US$47.35 | -2.29% | 685,279 |
| 26-07-10 | US$48.46 | -0.59% | 1,126,231 |
| 26-07-09 | US$48.75 | -3.35% | 1,296,246 |
| 26-07-08 | US$50.44 | +5.21% | 1,430,876 |
| 26-07-07 | US$47.94 | +1.48% | 1,017,845 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SUPN Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition